Diagnosis-Related Group-Based Payments for Adult Spine Deformity Surgery Significantly Vary across Centers: Results from a Multicenter Prospective Cohort Study.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 16 07 2022
revised: 23 11 2022
accepted: 24 11 2022
pubmed: 2 12 2022
medline: 8 3 2023
entrez: 1 12 2022
Statut: ppublish

Résumé

To investigate the variation in total episode-of-care (EOC) payment and quality-adjusted life-year (QALY) gain for complex adult spine deformity surgeries in the United States, adjusting for case type and surgeon preferences. Patients aged >18 years with adult spine deformity with Medicare Severity-Diagnosis-Related Groups (DRGs) 453-460 and a minimum of 2 years of follow-up from index surgery were included. Index and total payments were calculated using Medicare's Inpatient Prospective Payment System. All costs were adjusted for inflation to 2020 U.S. dollar values. QALYs gained were calculated using baseline, 1-year, and 2-year Short-Form 6D scores. Mixed-effect models were used to estimate the proportion of variation in total EOC payment and QALY gain. A total of 330/543 patients from 6 sites were included. Mean age was 62.4 ± 11.9 years, 79% were women, and 92% were white. The mean index and total EOC payment were $77,302 and $93,182, respectively. Patients gained on average 0.15 QALY (P < 0.0001) 2 years after surgery. In unadjusted analysis, 39% of the variation in total EOC payment across the 6 centers was attributable to relative weight of DRG and base rate. Adjusting for patient and procedural factors increased the proportion of variation in total EOC payments across the centers to 56%. Less than 2% of the variation in QALY gain was observed across the 6 centers. Medicare-based payments for complex spine deformity fusions are primarily driven by relative weight of the DRG and the hospital's base rate. Patient and procedural factors are unaccounted for in the DRG-based payments made to the providers.

Sections du résumé

BACKGROUND BACKGROUND
To investigate the variation in total episode-of-care (EOC) payment and quality-adjusted life-year (QALY) gain for complex adult spine deformity surgeries in the United States, adjusting for case type and surgeon preferences.
METHODS METHODS
Patients aged >18 years with adult spine deformity with Medicare Severity-Diagnosis-Related Groups (DRGs) 453-460 and a minimum of 2 years of follow-up from index surgery were included. Index and total payments were calculated using Medicare's Inpatient Prospective Payment System. All costs were adjusted for inflation to 2020 U.S. dollar values. QALYs gained were calculated using baseline, 1-year, and 2-year Short-Form 6D scores. Mixed-effect models were used to estimate the proportion of variation in total EOC payment and QALY gain.
RESULTS RESULTS
A total of 330/543 patients from 6 sites were included. Mean age was 62.4 ± 11.9 years, 79% were women, and 92% were white. The mean index and total EOC payment were $77,302 and $93,182, respectively. Patients gained on average 0.15 QALY (P < 0.0001) 2 years after surgery. In unadjusted analysis, 39% of the variation in total EOC payment across the 6 centers was attributable to relative weight of DRG and base rate. Adjusting for patient and procedural factors increased the proportion of variation in total EOC payments across the centers to 56%. Less than 2% of the variation in QALY gain was observed across the 6 centers.
CONCLUSIONS CONCLUSIONS
Medicare-based payments for complex spine deformity fusions are primarily driven by relative weight of the DRG and the hospital's base rate. Patient and procedural factors are unaccounted for in the DRG-based payments made to the providers.

Identifiants

pubmed: 36455841
pii: S1878-8750(22)01658-8
doi: 10.1016/j.wneu.2022.11.107
pii:
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e153-e161

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Samrat Yeramaneni (S)

Department of Orthopedic Surgery, Medical City Dallas, Dallas, Texas, USA. Electronic address: samrat.yeramaneni@hcahealthcare.com.

Kevin Wang (K)

Department of Orthopedic Surgery, The Johns Hopkins University, Baltimore, Maryland, USA.

Jeffrey Gum (J)

Norton Leatherman Spine Center, Louisville, Kentucky, USA.

Breton Line (B)

Department of Orthopedic Surgery, Rocky Mountain Hospital for Children, Denver, Colorado, USA.

Amit Jain (A)

Department of Orthopedic Surgery, The Johns Hopkins University, Baltimore, Maryland, USA.

Khaled Kebaish (K)

Department of Orthopedic Surgery, The Johns Hopkins University, Baltimore, Maryland, USA.

Christopher Shaffrey (C)

Department of Neurosurgery, Duke University, Raleigh, North Carolina, USA.

Justin S Smith (JS)

Department of Neurosurgery, University of Virginia, Virginia, USA.

Virginie Lafage (V)

Department of Orthopedic Surgery, Lenox Hill Hospital, Northwell, New York City, New York, USA.

Frank Schwab (F)

Department of Orthopedic Surgery, Lenox Hill Hospital, Northwell, New York City, New York, USA.

Peter Passias (P)

Division of Spine Surgery, Department of Orthopedic Surgery, New York, New York, USA.

D Kojo Hamilton (DK)

University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Eric Klineberg (E)

Department of Orthopedic Surgery, University of California Davis Medical Center, Sacramento, California, USA.

Christopher Ames (C)

Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.

Douglas Burton (D)

Department of Orthopedic Surgery, University of Kansas Medical Center, Kansas City, Kansas, USA.

Shay Bess (S)

Department of Orthopedic Surgery, Rocky Mountain Hospital for Children, Denver, Colorado, USA.

Richard Hostin (R)

Department of Orthopedic Surgery, Medical City Dallas, Dallas, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH